Effects of isoflurane-induced anaesthesia on cognitive performance in a mouse model of Alzheimer's disease A randomised trial in transgenic APP23 mice

被引:11
|
作者
Eckel, Barbara [1 ,2 ]
Ohl, Frauke [3 ]
Starker, Laura [1 ]
Rammes, Gerhard [1 ]
Bogdanski, Ralph [1 ]
Kochs, Eberhard [1 ]
Blobner, Manfred [1 ]
机构
[1] Tech Univ Munich, Klinikumrechts Isar, Klin Anaesthesiol, D-81675 Munich, Germany
[2] RoMed Klinikum Rosenheim, Klin Anasthesie, Rosenheim, Germany
[3] Univ Utrecht, Fac Vet Med, Lab Anim Sci, Dept Anim Sci & Soc, Utrecht, Netherlands
关键词
APP23 TRANSGENIC MICE; MODIFIED HOLE BOARD; GENERAL-ANESTHESIA; CONSENSUS STATEMENT; ANIMAL-MODELS; EXPOSURE; BEHAVIOR; RATS; DISORDERS; NEUROTOXICITY;
D O I
10.1097/EJA.0b013e32835b824b
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUNDResults from in-vitro experiments suggest that inhalational anaesthetics may have a detrimental effect on the course and incidence of Alzheimer's disease. However, case-control studies in humans show no negative impact of anaesthetics on the course of Alzheimer's disease.OBJECTIVETo test the hypothesis that 2h of general anaesthesia with 1 MAC isoflurane changes learning abilities of young and old transgenic Alzheimer's mice (APP23 mice).DESIGNRandomised controlled double-blinded study in mice.SETTINGAnimal laboratory and operating theatre in the Klinik fur Anasthesiologie, Technische Universitat Munchen, GermanyANIMALSNinety-six male mice divided in four groups: young (4 months) APP23 mice and corresponding wild-type mice; old (14 to 16 months) APP23 and corresponding wild-type mice.INTERVENTIONMice were either anaesthetised for 2h with 1 MAC isoflurane or sham-anaesthetised (isoflurane' or control').MAIN OUTCOME MEASURESLearning and locomotor activity during the following 8 days using the modified Hole Board Test for mice. Results are median (interquartile range) and median difference (95% confidence interval).RESULTSYoung mice, [1.0 (1.3)] as assessed by the number of omission errors, learned better than old [1.8 (1.8); age: P=0.004, median difference 0.5 (0.2 to 1.0)]. Anaesthetised animals [0.8 (1.5)] learned better than controls [1.6 (1.7); anaesthesia: P=0.010, median difference 0.5 (0.1 to 0.9)]. This was accompanied by higher locomotor activity in young compared to old mice as assessed by number of line crossings per minute [10 (5) min(-1) vs. 7 (3) min(-1), P<0.001, median difference 3 (2 to 4)min(-1)]. Anaesthesia and genotype Alzheimer's disease had no impact on locomotor activity.CONCLUSIONIsoflurane may have protective, rather than detrimental, effects on cognition in Alzheimer's disease.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [1] Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model
    Sturchler-Pierrat, C
    Staufenbiel, M
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 134 - 139
  • [2] APP23 mice as a model of Alzheimer's disease: An example of a transgenic approach to modeling a CNS disorder
    Van Dam, D
    Vloeberghs, E
    Abramowski, D
    Staufenbiel, M
    De Deyn, PP
    CNS SPECTRUMS, 2005, 10 (03) : 207 - 222
  • [3] Changes in extracellular space size and geometry in APP23 transgenic mice:: A model of Alzheimer's disease
    Syková, E
    Vorísek, I
    Antonova, T
    Mazel, T
    Meyer-Luehmann, M
    Jucker, M
    Hájek, M
    Or, M
    Bures, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) : 479 - 484
  • [4] Synergistic Effects of Antidementia Drugs on Spatial Learning and Recall in the APP23 Transgenic Mouse Model of Alzheimer's Disease
    Neumeister, Katharina L.
    Riepe, Matthias W.
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (02) : 245 - 251
  • [5] Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease
    Debby Van Dam
    Katrien Coen
    Peter Paul De Deyn
    Psychopharmacology, 2008, 197 : 37 - 43
  • [6] Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease
    Van Dam, Debby
    Coen, Katrien
    De Deyn, Peter Paul
    PSYCHOPHARMACOLOGY, 2008, 197 (01) : 37 - 43
  • [7] Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model
    Schreyer, Stefanie
    Klein, Charlotte
    Pfeffer, Anna
    Rasinska, Justyna
    Stahn, Laura
    Knuth, Karlotta
    Abuelnor, Basim
    Panzel, Alina Elisabeth Catharina
    Rex, Andre
    Koch, Stefan
    Hemmati-Sadeghi, Shabnam
    Steiner, Barbara
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] Chia seeds as a potential cognitive booster in the APP23 Alzheimer’s disease model
    Stefanie Schreyer
    Charlotte Klein
    Anna Pfeffer
    Justyna Rasińska
    Laura Stahn
    Karlotta Knuth
    Basim Abuelnor
    Alina Elisabeth Catharina Panzel
    André Rex
    Stefan Koch
    Shabnam Hemmati-Sadeghi
    Barbara Steiner
    Scientific Reports, 10
  • [9] The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer's Disease
    Wilhelmus, Micha M. M.
    Tonoli, Elisa
    Coveney, Clare
    Boocock, David J.
    Jongenelen, Cornelis A. M.
    Breve, John J. P.
    Verderio, Elisabetta A. M.
    Drukarch, Benjamin
    CELLS, 2022, 11 (03)
  • [10] Validation of the APP23 transgenic mouse model of Alzheimer's disease through evaluation of risperidone treatment on aggressive behaviour
    Vloeberghs, Ellen
    Coen, Katrien
    Van Dam, Debby
    De Deyn, Peter Paul
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2008, 58 (06): : 265 - 268